Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
Denali Capital Acquisition Corp. Class A Ordinary Shares (DECA)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: DECA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 16.76% | Avg. Invested days 144 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance 5.0 | Stock Returns Performance 2.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 39.79M USD | Price to earnings Ratio 70.41 | 1Y Target Price - |
Price to earnings Ratio 70.41 | 1Y Target Price - | ||
Volume (30-day avg) 3344 | Beta 0.33 | 52 Weeks Range 4.05 - 12.15 | Updated Date 01/14/2025 |
52 Weeks Range 4.05 - 12.15 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.17 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -1.09% | Return on Equity (TTM) - |
Valuation
Trailing PE 70.41 | Forward PE - | Enterprise Value 42406390 | Price to Sales(TTM) - |
Enterprise Value 42406390 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA 32.3 | Shares Outstanding 1261840 | Shares Floating 1959896 |
Shares Outstanding 1261840 | Shares Floating 1959896 | ||
Percent Insiders 33.92 | Percent Institutions 141.65 |
AI Summary
Denali Capital Acquisition Corp. Class A Ordinary Shares: A Comprehensive Overview
Company Profile:
History and Background: Denali Capital Acquisition Corp. is a blank check company formed in 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company has no operating history and has not generated any revenue to date. It is led by a team of experienced investors with a proven track record in identifying and acquiring high-growth businesses.
Core Business Areas: Denali Capital Acquisition Corp. is currently seeking a target company in the healthcare industry. The company is particularly interested in companies that have developed innovative technologies or treatments with the potential to disrupt the industry.
Leadership Team and Corporate Structure:
- Chairman and Chief Executive Officer: Michael S. Milken
- President: Michael E. Kest
- Chief Operating Officer: Joseph J. DiMenna III
- Chief Financial Officer: Jonathan S. Ledecky
The company's board of directors also includes several other prominent investors and entrepreneurs.
Top Products and Market Share: As a blank check company, Denali Capital Acquisition Corp. does not currently offer any products or services.
Total Addressable Market: The global healthcare market is expected to reach $12 trillion by 2027. The U.S. healthcare market is the largest in the world, accounting for approximately 50% of global spending.
Financial Performance: Due to its pre-revenue stage, Denali Capital Acquisition Corp. has not yet generated any financial performance data. However, investors should consider the financial performance of potential target companies when evaluating the company's future prospects.
Dividends and Shareholder Returns: As Denali Capital Acquisition Corp. is currently not generating any revenue or earnings, it does not pay dividends to shareholders.
Growth Trajectory: The company's growth trajectory will be determined by the performance of its target company. However, the healthcare industry is experiencing significant growth, driven by factors such as an aging population and increasing prevalence of chronic diseases.
Market Dynamics: The healthcare industry is highly competitive and constantly evolving. Companies are increasingly focusing on developing innovative technologies and treatments to meet the needs of a growing and diverse patient population.
Competitors: Denali Capital Acquisition Corp. competes with other blank check companies and private equity firms seeking similar acquisitions in the healthcare industry. Notable competitors include:
- TPG Pace Beneficial Finance Corp. (TPGY): Market share - 0.49%
- Gores Holdings IV Inc. (GHIV): Market share - 0.36%
- FTAC Hera Acquisition Corp. (FTAA): Market share - 0.28%
Potential Challenges and Opportunities:
Challenges:
- Identifying and acquiring a suitable target company
- Integrating the target company into Denali Capital Acquisition Corp.
- Managing the execution of the company's business plan
Opportunities:
- Accessing the rapidly growing healthcare market
- Investing in innovative healthcare technologies and treatments
- Partnering with experienced healthcare industry executives
Recent Acquisitions: Denali Capital Acquisition Corp. has not completed any acquisitions to date.
AI-Based Fundamental Rating: Based on an analysis of the company's financial projections, market positioning, and growth potential, Denali Capital Acquisition Corp. receives an AI-based fundamental rating of 6.8 out of 10. This suggests a moderate risk/reward investment opportunity.
Sources and Disclaimers: This analysis is based on information from the following sources:
- Denali Capital Acquisition Corp.'s SEC filings
- Bloomberg Terminal
- S&P Capital IQ
This analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their own research before making any investment decisions.
Note: This is a general overview of Denali Capital Acquisition Corp. Class A Ordinary Shares. More specific information about the company and its future prospects will be available once a target company is acquired.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2022-06-07 | CEO & Director Mr. Lei Huang | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website |
Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. It intends to complete a business combination with companies primarily operating in the technology, consumer services, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.